Olympus Corp. receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Olympus Corp. (7733)
The Olympus Corp. share price today is 1,546.5, view TYO 7733 stock exchange data. Track the latest Olympus Corp. share price with real-time updates on 7733 stock performance including market cap, day range, 52-week range and dividend yield. Access 7733 charts, earnings dates and analyst estimates to support your investment decisions.
1,546.5
-17.5(-1.12%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,526.5
1,563.0
52 wk Range
1,302.5
2,168.0
Earnings results expected in 12 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,526.51,563.0
52 wk Range
1,302.52,168.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.93%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.93%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
7733 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
1,750.0
Upside
+13.16%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 6 consecutive years
- Olympus Corp. receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Olympus Corp. receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Olympus Corp. receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Olympus Corp. receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Olympus Corp. receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Olympus Corp. receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
4 Buy
9 Hold
1 Sell
Ratings:
14 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 1,750.0
(+13.16% Upside)
Olympus Corp. Earnings Call Summary for Q3/2026
- Olympus Corp. revised Q3 2025 revenue guidance down 2%, causing stock to fall 5.22% to 1954.5 yen amid U.S. market challenges.
- The company targets margin expansion of 100+ basis points from FY 2027 and has increased structural cost reduction to JPY 31 billion.
- Despite reduced gross margins due to ship holds and inventory actions, Olympus forecasts a return to growth in Q4 with mid-single-digit revenue targets.
- CEO Bob emphasized leadership transformation and maintained the company's commitment to 20%+ operating margin goals despite current challenges.
- New product launches in the GI segment are planned as part of the company's strategy to overcome supply chain issues and competitive pressures.
Last Updated: 13-02-2026, 11:44 pm
Read Full TranscriptEarnings
Latest Release
13-02-2026
EPS / Forecast
12.87 / 22.56
Revenue / Forecast
261.05B / 259.88B
Compare 7733 to Peers and Sector
Metrics to compare | 7733 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship7733PeersSector | |
|---|---|---|---|---|
P/E Ratio | 20.3x | 19.2x | −0.5x | |
PEG Ratio | 4.41 | 0.88 | 0.00 | |
Price/Book | 2.2x | 2.0x | 2.6x | |
Price / LTM Sales | 1.7x | 1.9x | 3.2x | |
Upside (Analyst Target) | 8.7% | 27.4% | 50.8% | |
Fair Value Upside | Unlock | 23.8% | 7.7% | Unlock |
Olympus Corporation, together with its subsidiaries, manufactures and sells medical equipment in Japan, America, the Middle East, Asia, and Oceania. It operates through Endoscopic Solutions Business, Therapeutic Solutions Business, and Other segments. The company offers gastrointestinal endoscopy system products comprising video endoscopy and ultrasound systems; GI endotherapy products consisting of CRC devices and HPB devices/hemostasis products; endoscopic solutions ecosystem products, including intelligent ecosystem operating software platforms, and AI insights and computer-aided detection/diagnosis products; reprocessing products, such as endoscope reprocessors, chemicals, accessories, and peripherals; and medical services, which include repair center services. It also provides respiratory products comprising bronchoscopy systems and devices, lung cancer products, and chronic obstructive pulmonary disease products; urology products consisting of visualization, stone management, benign prostatic hyperplasia (BPH), and BPH + bladder cancer products; surgical products, such as surgical endoscopy systems, advanced energy devices, surgical microscope, integrated procedure room solutions, and rhino-laryngoscopy systems, as well as surgical devices for the ears, nose, and throat; and gastroenterology devices and gynecology products. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Hachioji, Japan.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Olympus Corp. (7733) Share Price Today?
The Olympus Corp. share price today is 1,546.5.
What is the current Olympus Corp. (7733) share price and day range?
As of 30-04-2026, the Olympus Corp. share price is 1,546.5, with a previous close of 1,564.0. The share price has ranged from 1,526.5 to 1,563.0 today, while the 52-week range spans from 1,302.5 to 2,168.0.
What Is the Olympus Corp. Market Cap?
As of today, Olympus Corp. market cap is 1.7T.
Does Olympus Corp. Pay Dividends? What's The Current Dividend Yield?
The Olympus Corp. dividend yield is 1.93%.
What Is the Olympus Corp. (7733) Share Price Target?
The average 12-month share price target for Olympus Corp. is 1,750.0, with a high estimate of 2300 and a low estimate of 1500. 4 analysts recommend buying, while 1 suggest selling, with an overall rating of Neutral and +13.16% Upside potential.
What Is Olympus Corp.'s Earnings Per Share (TTM)?
The Olympus Corp. EPS (TTM) is 75.7.
When Is the Next Olympus Corp. Earnings Date?
Olympus Corp. will release its next earnings report on 12-05-2026.
From a Technical Analysis Perspective, Is 7733 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Olympus Corp. Trade On?
Olympus Corp. is listed and trades on the Tokyo Stock Exchange.
What Is the Stock Symbol for Olympus Corp.?
The stock symbol for Olympus Corp. is "7733."
How Many Times Has Olympus Corp. Stock Split?
Olympus Corp. has split 1 times.
How Many Employees Does Olympus Corp. Have?
Olympus Corp. has 29297 employees.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.